Textbook of bladder cancer / edited by Seth P. Lerner, Mark P. Schoenberg, Cora N. Sternberg.

Other author Lerner, Seth P.
Other author Schoenberg, Mark P.
Other author Sternberg, Cora N.
Format Book
Publication InfoAbingdon, Oxon ; Boca Raton : Taylor & Francis, 2006.
Descriptionxvii, 786 pages : illustrations (some color) ; 29 cm
Subjects
Urinary Bladder Neoplasms.

Contents Epidemiology of bladder cancer -- Occupational risk factors -- Familial bladder cancer -- Genetic susceptibility to bladder cancer -- Urothelial carcinoma and its variants -- WHO/ISUP grading system -- Urothelial bladder tumor pathology: contemporary consensus classification and diagnosis based on the World Health Organization (WHO) 1973 classification -- Non-urothelial tumors -- Gene discovery (overview) -- Molecular biology of bladder cancer: cell cycle alterations -- Cytogenetics of urothelial neoplasis -- Gene microarrays -- Molecular biology of invasive and metastatic urothelial cancer -- Animal models of bladder cancer -- Animal models: naturally ocurring canine urinary bladder cancer -- Cystoscopy -- Floresence endoscopy -- Imaging in the assessment of urinary bladder carcinoma -- Cytology and DNA ploidy -- Voided urine markers -- Staging -- Etiology and management of urothelial tumors of the renal pelvis and ureter -- Early detection for bladder cancer -- Natural history of stages Ta, T1, and Tis urothelial cancer in the urinary bladder -- Risk stratification of Ta, Tis, T1 cancer -- Issues in staging of Ta, Tis, T1 bladder cancers -- Transurethral resection of bladder tumors -- Laser ablation and other technology -- Perioperative instillation of chemotherapeutic drugs -- The role of intravesical chemotherapy in the treatment of bladder cancer: optimization and novel agents -- Intravesical chemotherapy of superficial bladder cancer: -- Intravesical immunotherapy: BCG -- Mode of action of BCG and rationale for combination immunotherapy -- Marker tumor concept: ethical issues -- The use of the marker tumor concept in Ta, T1 bladder cancer: is it justified? -- Photodynamic therapy -- G3T1 bladder carcinoma -- What to do when BCG fails -- Chemoprevention of superficial bladder cancer -- Surrogate endpoint biomarkers -- Follow-up strategies in superficial bladder cancer -- The natural history of invasive bladder cancer -- Selection and perioperative management of patients undergoing radical cystectomy and urinary reconstruction -- Radical cystectomy - technique and outcomes -- Cystectomy in the female -- Nerve-sparing radical cystectomy -- Laparoscopic radical cystectomy and urinary diversion -- Role of extended pelvic lymphadenectomy -- Role of sentinel node detection -- Management of the urethra in the cystectomy patient -- Role of radical cystectomy in patients with unresectable and/or locoregionally metastatic bladder cancer -- Radical TURBT -- Partial cystectomy -- Optimal radiotherapy for bladder cancer -- Trimodality therapy in the management of muscle-invasive bladder cancer: a selective organ-preserving approach -- Orthotopic neobladder -- Continent cutaneous diversion -- Noncontinent urinary diversion -- Metabolic aspects of diversion -- Psychosocial and quality-of-life issues -- Tissue engineering of the bladder -- Clinical trial design -- Neo-adjuvant chemotherapy in the treament of muscle-invasive bladder cancer -- Adjuvant chemotherapy for invasive bladder cancer -- Treatment of metastic cancer -- Special considerations in the elderly patient -- Targeted therapy for bladder cancer -- Bladder cancer gene therapy -- Treatment of non-TCC adenocarcinoma/sarcoma -- Treatment of squamous cell carcinoma -- Pediatric bladder tumours -- Bladder cancer internet resources -- Support groups -- Education and counseling of the cystectomy patient.
Bibliography noteIncludes bibliographical references and index.
ISBN1841843822 :
ISBN9781841843827

Availability

Library Location Call Number Status Item Actions
Laupus Books - Stacks WJ 504 T355 2006 ✔ Available Place Hold